GenVec, Inc. (GNVC) Announces Partnership with World-Leading Animal Health Company
Today, GenVec, Inc. announced that it will be working with Merial to develop and commercialize GenVec's proprietary vaccine technology for use against foot-and-mouth disease (FMD). The leading FMD vaccine producer in the world, Merial has leading positions in all key markets. Under the agreement, Merial will be responsible for all costs related to the development and commercialization of FMD vaccines developed through the collaboration. GenVec's novel FMD vaccine approach utilizes the company's proprietary adenovector technology. The vaccine is manufactured on a proprietary GenVec cell line that is capable of producing antigens without the use of the highly contagious FMD virus.…